Subject Enrollment Completed for International Multicenter Comparative Clinical (Phase 3) Study of Boan Biotech's Denosumab
- Written by PR Newswire
A meeting was also held in Germany to announce the results of the international pharmacokinetic similarity clinical (Phase 1) study
BERLIN, Jan. 12, 2024 /PRNewswire/ -- Boan Biotech recently announced that subject enrollment for the international multicenter comparative clinical (Phase 3) study of the company's Denosumab Injections (BA6101...














